$ETST “We are on the cusp of making tremendous progress in our clinical trial efforts,” said Dr. Michel Aubé, CEO and CSO of ETST. He continued, “Our partnership with BNK will allow us to leverage the expertise of R&D veterans of many years, which will help us move more quickly, develop more products, cut costs, and ultimately, treat more patients.”